Background
Diabetes mellitus is a leading cause of morbidity and mortality in Western countries. To prevent diabetic chronic complications, various trials have validated the need for tight glycemic control [1] . Important laboratory markers used in the follow-up of diabetic patients include glycated hemoglobin (HbA1c) [2, 3] and microalbuminuria [3] , an important predictor of diabetic nephropathy.
The aim of this study is to evaluate HbA1c as a significant index of glycemic control, and to determine the prevalence of microalbuminuria in elderly diabetic patients in our geographic area.
Materials and methods
HbA1c levels were measured using a high-pressure liquid chromatography methodology (HA 8160, Menarini Diagnostics), and analysed in 352 consecutive diabetic patients (age: >41 years) within a two month time period (September-October 2009). The optimal HbA1c target for diabetic patients was considered <7%, as recommended by the American Diabetes Association. Urinary albumin levels were measured by an immunoturbidimetric assay (BN II, Dade Behring) in 226 consecutive diabetic patients (age: >41 years) within the same time period. Microalbuminuria was diagnosed if albumin in urine samples was > 30 mg/L.
Results
Within the patients examined, the overall HbA1c mean is 6.95% +1.51, and the overall prevalence of high HbA1c (>7%), indicative of poor glycemic control, is 34.4%. Interestingly, the prevalence of patients with high HbA1c is over 30% in any age range examined, with a peak in the age range 61-70 (Table 1) . However, while the overall prevalence of microalbuminuria is 19.2%, in agreement with data reported by the Italian Ministry of Health, microalbuminuria is diagnosed in about 8% of diabetics under 60 years, and in almost 30% of patients over 60 years (Table 2 ).
Conclusions
Our data indicate that a sub-optimal glycemic control is observed in more than 30% of the diabetics examined, regardless of age. Furthermore, our data confirm that older age is associated with an increased risk of microalbuminuria and progressive impairment of renal function. 
